Literature DB >> 9594920

The role of the gamma knife in the treatment of malignant primary and metastatic brain tumors.

R F Young1.   

Abstract

Gamma knife treatment is a clinically effective, safe, and cost-effective adjunctive therapy for primary malignant brain tumors. For most brain metastases, radiosurgery is the treatment of choice and will result in effective tumor control in more than 90% of treated tumors.

Entities:  

Mesh：

Year:  1998        PMID： 9594920     DOI： 10.3322/canjclin.48.3.177

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  6 in total

1.  Stereotactic body radiation therapy for nonresectable tumors of the pancreas.

Authors:  Kush Goyal; Douglas Einstein; Rafael A Ibarra; Min Yao; Charles Kunos; Rod Ellis; James Brindle; Deepjot Singh; Jeffrey Hardacre; Yuxia Zhang; Jeffrey Fabians; Gary Funkhouser; Mitchell Machtay; Juan R Sanabria
Journal:  J Surg Res       Date:  2011-09-05       Impact factor: 2.192

2.  Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results.

Authors:  K Goyal; D Einstein; M Yao; C Kunos; F Barton; D Singh; C Siegel; J Stulberg; J Sanabria
Journal:  HPB Surg       Date:  2010-06-28

3.  Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma.

Authors:  Hiroyuki Kato; Hideo Yoshida; Hiroyoshi Taniguch; Ryutaro Nomura; Kengo Sato; Ichiro Suzuki; Ryo Nakata
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

4.  Dosimetric comparison of Gamma Knife® IconTM and linear accelerator-based fractionated stereotactic radiotherapy (FSRT) plans for the re-irradiation of large (>14 cm3) recurrent glioblastomas.

Authors:  Matthew E Schelin; Haisong Liu; Ayesha Ali; Wenyin Shi; Yan Yu; Karen E Mooney
Journal:  J Radiosurg SBRT       Date:  2021

5.  The effect of fractionated gamma knife radiosurgery on visual acuity in patients with optic nerve tumor.

Authors:  Farid Kazemi; Mazyar Azar; Foad Kazemi; Tahereh Hadisinia; Javad Teymori; Ghazale Geraily
Journal:  Rep Pract Oncol Radiother       Date:  2021-12-30

6.  [11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.

Authors:  Christian Pötzi; Alexander Becherer; Christine Marosi; Georgios Karanikas; Monika Szabo; Robert Dudczak; Kurt Kletter; Susanne Asenbaum
Journal:  J Neurooncol       Date:  2007-05-11       Impact factor: 4.506
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.